Why Asbestos Doesn’t Affect Everyone the Same Way
Most people assume asbestos risk follows a simple rule: more exposure equals more danger. But that’s only part of the picture. Decades of scientific research have made one thing increasingly clear — exploring the genetic link in asbestos-related diseases is now one of the most consequential areas of occupational health science, revealing why two people exposed to identical conditions can face dramatically different health outcomes.
The implications stretch far beyond the laboratory. They affect workers, property owners, and anyone with a history of asbestos exposure. Understanding how inherited gene mutations interact with asbestos fibres is reshaping early detection, risk assessment, and long-term health monitoring for thousands of people across the UK.
This isn’t purely academic. It has direct bearing on how we protect people today — and on why managing asbestos in buildings remains a serious legal and moral obligation, regardless of who is inside them.
Why Some People Are Far More Vulnerable Than Others
Asbestos-related conditions — including mesothelioma, asbestosis, and asbestos-related lung cancer — do not develop in every person who encounters the material. Exposure level and duration matter enormously, but they don’t explain everything.
Genetic predisposition is now understood to be a major contributing factor. Some individuals carry inherited mutations that make their cells far less capable of resisting the damage asbestos fibres cause — and the consequences can be devastating.
Two people working in the same building, breathing the same air, can face very different health outcomes depending entirely on what’s written in their DNA. That reality changes how we should approach asbestos risk assessment and health monitoring — and it makes a one-size-fits-all approach to managing asbestos risk scientifically indefensible.
The BAP1 Gene: A Critical Piece of the Puzzle
One gene has attracted more scientific attention than any other in this field: BAP1, or BRCA1-associated protein 1. BAP1 is a tumour suppressor gene — when it functions correctly, it regulates cell growth and prevents the uncontrolled division that leads to cancer. When BAP1 is mutated, that protective function breaks down entirely.
Researcher Dr Michele Carbone linked BAP1 mutations to a hereditary cancer syndrome that includes mesothelioma and uveal melanoma. A landmark study published in the Journal of Clinical Oncology identified BAP1 mutations across 26 families, providing compelling evidence that this genetic change is heritable.
The figures that emerged from this research are striking. Approximately 12% of people carrying BAP1 mutations go on to develop mesothelioma — a figure that rose to around 50% in some high-risk family cohorts where environmental asbestos exposure was also a significant factor.
These numbers illustrate precisely why exploring the genetic link in asbestos-related diseases matters so much in a clinical and public health context. This isn’t a marginal finding — it’s a fundamental shift in how we understand who is most at risk.
Genetic Biomarkers: Reading the Molecular Fingerprint
Beyond BAP1, researchers have identified a range of genetic biomarkers that can signal elevated risk or help confirm an asbestos-related diagnosis. These markers provide a molecular fingerprint of how asbestos exposure interacts with an individual’s genetic makeup.
Three Genes at the Centre of Mesothelioma Research
Three genes in particular have emerged as especially important in the detection and study of asbestos-related diseases:
- CDKN2A — a tumour suppressor gene frequently deleted or silenced in mesothelioma cases
- NF2 — mutations in this gene are found in a significant proportion of mesothelioma diagnoses
- TP53 — one of the most widely studied cancer-related genes, also implicated in asbestos-related lung disease
Research has also identified six genes — TIMP3, SLIT2, RARB, CCND2, APC, and RASSF1 — that carry specific methylation patterns associated with both asbestos exposure and mesothelioma. Detecting these patterns can help clinicians identify disease at an earlier, more treatable stage.
Single Nucleotide Polymorphisms and Lung Cancer Risk
Genome-wide association studies have identified specific single nucleotide polymorphisms (SNPs) — tiny variations in DNA — that appear to increase lung cancer risk in people exposed to asbestos. Four SNPs in particular have been associated with elevated risk, with odds ratios ranging from 1.24 to 1.34.
Even small genetic variations can meaningfully influence an individual’s susceptibility to asbestos-related lung cancer. This reinforces the case for personalised risk assessment in occupationally exposed populations, rather than treating all exposed workers as facing identical risk.
Epigenetic Changes: When Asbestos Rewrites How Your Genes Behave
Genetics isn’t only about the DNA you’re born with. Asbestos exposure can alter how genes behave without changing the DNA sequence itself — a process known as epigenetics. These changes can switch protective genes off and allow cancer-promoting genes to become overactive.
DNA Methylation and the Silencing of Tumour Suppressors
One of the most well-documented epigenetic effects of asbestos exposure is DNA methylation — the addition of chemical tags to DNA that effectively silence tumour suppressor genes. When these protective genes are switched off, oncogenes that promote uncontrolled cell growth can take over.
Research has demonstrated hypermethylation of the p16, RASSF1A, and APC genes in lung cancer cases linked to asbestos exposure. Statistical modelling has estimated that asbestos-related epigenetic changes carry a measurable and significant association with lung cancer risk at a population level.
MicroRNA and the Let-7 Pathway
MicroRNAs are small molecules that regulate gene expression. The let-7 microRNA acts as a key tumour suppressor, and reduced levels of let-7 have been linked to poor prognosis in lung cancer. Asbestos exposure has been shown to disrupt let-7 activity, adding another molecular layer to how this material causes long-term harm.
This is a rapidly evolving area of research, and the implications for treatment development and early detection are considerable.
The Compounding Effect of Smoking
Smoking doesn’t simply add to the risk posed by asbestos exposure — it multiplies it. Tobacco smoke and asbestos fibres work together to cause greater DNA damage than either would produce alone.
Research has identified a specific variant in the CHRNA5 gene that appears to mediate some of this combined risk, with a statistically significant association in studies of lung cancer among asbestos-exposed smokers.
For anyone with a history of both smoking and asbestos exposure, the genetic risk profile is considerably more complex — and the case for regular, proactive health monitoring is correspondingly stronger. A wait-and-see approach is not appropriate for this group.
Liquid Biopsies: A Less Invasive Route to Detection
One of the most promising practical developments to emerge from this area of research is the liquid biopsy. Unlike traditional tissue biopsies, which require surgical procedures, liquid biopsies analyse genetic material circulating in the bloodstream — including DNA shed by tumour cells.
This approach can detect mutations, methylation patterns, and other genetic changes associated with mesothelioma and asbestos-related lung cancer with significantly less discomfort and risk to the patient. For individuals at elevated genetic risk, liquid biopsies offer a practical surveillance tool that could enable earlier diagnosis and meaningfully better outcomes.
Liquid biopsies can also identify the SNPs discussed earlier, helping clinicians build a more complete picture of an individual’s genetic susceptibility before symptoms appear. The earlier a diagnosis is made, the more treatment options are available.
Exploring the Genetic Link in Asbestos-Related Diseases: What It Means in Practice
The science has a direct practical implication that extends well beyond the laboratory: asbestos risk is not uniform. Two people working in the same building, exposed to the same asbestos-containing materials, may face very different health outcomes depending on their genetic makeup.
This does not reduce the obligation to manage asbestos safely — it reinforces it. The Control of Asbestos Regulations place clear legal duties on those responsible for non-domestic premises to identify, assess, and manage asbestos-containing materials. Compliance with HSE guidance, including HSG264, is not optional regardless of who is in the building or what their genetic profile might be.
What the genetic research adds is a compelling argument for treating asbestos management as a serious, individualised health matter — not simply a regulatory box to tick. The science gives us reason to take the duty of care more seriously, not less.
Who Should Consider Genetic Risk Assessment?
If you or a family member has a history of mesothelioma, or if you have worked in industries with known asbestos exposure — construction, shipbuilding, insulation work, plumbing, and others — it may be worth discussing genetic risk assessment with a specialist.
Key groups who might benefit include:
- Individuals with a family history of mesothelioma or uveal melanoma
- Workers with documented occupational asbestos exposure
- People who lived or worked in buildings later found to contain damaged asbestos materials
- Smokers with any history of asbestos exposure
Genetic testing and counselling in this context is a matter for qualified medical professionals. Your GP or an occupational health specialist is the right starting point if you have concerns. Early conversations can make a significant difference to outcomes.
The Other Side of the Equation: Knowing Whether Asbestos Is Present
Understanding genetic risk is one piece of the puzzle. The other — and the one that can be acted on right now — is knowing whether asbestos is present in the buildings where people live and work.
Asbestos was widely used in UK construction until it was fully banned in 1999. Any building constructed or refurbished before that date may contain asbestos-containing materials in roofing, insulation, floor tiles, ceiling tiles, pipe lagging, textured coatings, and many other locations.
Without a professional survey carried out to HSG264 standards, it is impossible to know for certain what is present or what condition it is in. The genetic research discussed throughout this post makes one thing abundantly clear: some of the people using your building may be far more vulnerable to asbestos exposure than you realise.
That makes accurate identification and management of asbestos-containing materials not just a legal obligation but a genuine moral one.
Professional Asbestos Surveys Across the UK
For property owners and managers in the capital, our asbestos survey London service covers commercial, residential, and industrial properties across the city. Our fully qualified surveyors work in strict accordance with HSG264 and the Control of Asbestos Regulations, providing accurate, defensible reports you can rely on.
In the north-west, our asbestos survey Manchester service delivers the same high standard of professional assessment, helping property owners and duty holders meet their legal obligations and protect everyone who uses their buildings.
For clients in the Midlands, our asbestos survey Birmingham team works with property managers, local authorities, schools, and commercial clients to identify and document asbestos-containing materials accurately and efficiently.
With over 50,000 surveys completed nationwide, Supernova Asbestos Surveys has the experience and expertise to help you understand exactly what’s in your building — and what needs to be done about it. Call us on 020 4586 0680 or visit asbestos-surveys.org.uk to book a survey or discuss your requirements with our team.
Frequently Asked Questions
Does having a genetic mutation mean you will definitely develop an asbestos-related disease?
No. Carrying a mutation such as a BAP1 variant increases your risk, but it does not make disease inevitable. Risk is influenced by a combination of genetic factors, the level and duration of asbestos exposure, smoking history, and other environmental variables. Genetic testing provides a clearer picture of susceptibility — it doesn’t deliver a certain diagnosis.
Can genetic testing tell me whether I’ve been harmed by past asbestos exposure?
Genetic testing can identify inherited mutations and certain epigenetic changes associated with asbestos exposure, but it isn’t a diagnostic tool for disease in isolation. If you have concerns about past exposure, the right first step is to speak to your GP or an occupational health specialist, who can arrange appropriate clinical investigations alongside any genetic assessment.
Are some occupations at higher genetic risk from asbestos than others?
The genetic risk factors discussed in this article apply regardless of occupation. However, workers in construction, shipbuilding, insulation, plumbing, and building maintenance have historically faced the highest levels of occupational asbestos exposure — meaning that for those carrying genetic susceptibilities, the combination of elevated exposure and inherited risk is particularly significant.
What are the legal obligations for managing asbestos in UK buildings?
The Control of Asbestos Regulations place a duty on those responsible for non-domestic premises to manage asbestos-containing materials. This includes identifying what is present, assessing its condition and the risk it poses, and putting a management plan in place. HSE guidance document HSG264 sets out the standards for asbestos surveys. Failure to comply is a criminal offence.
How do I find out whether a building contains asbestos?
The only reliable way to establish whether asbestos-containing materials are present — and in what condition — is to commission a professional asbestos survey carried out by a qualified surveyor working to HSG264 standards. Visual inspection alone is not sufficient. Supernova Asbestos Surveys operates nationwide and can arrange a management or refurbishment survey depending on your needs. Call 020 4586 0680 or visit asbestos-surveys.org.uk to get started.